Metagenomi Ratios (2023-2025) | MGX

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -160.98%-98.00%-150.56%-133.62%-225.36%-64.66%-181.34%-255.94%-604.34%-233.34%-238.21%
EBIT Margin -207.21%-158.45%-181.15%-162.88%-260.17%-84.28%-194.40%-214.51%-674.10%-246.53%-263.76%
EBITDA Margin -186.12%-116.29%-159.75%-153.50%-226.98%-53.61%-146.51%-253.05%-608.84%-236.78%-235.52%
Operating Margin -207.21%-158.45%-181.15%-162.88%-260.17%-84.28%-194.40%-214.51%-674.10%-246.53%-263.76%
Net Margin -186.36%-114.74%-160.32%-155.61%-225.36%-53.67%-163.04%-243.37%-606.71%-233.85%-235.51%
FCF Margin -273.34%-257.93%-210.22%-180.09%-275.70%-134.82%-241.78%-276.78%-560.46%-251.12%-246.30%
Efficiency
Assets Average 390.12M400.65M372.13M341.47M311.23M285.07M260.11M
Equity Average -96.28M-51.33M-67.85M70.02M272.53M262.60M245.31M223.76M204.24M187.14M
Invested Capital -90.01M-102.54M-0.12M-135.58M275.63M269.42M255.77M234.86M212.66M195.83M178.45M
Asset Utilization Ratio 0.120.140.150.150.150.120.12
Leverage & Solvency
Equity Ratio -0.370.660.700.710.720.710.720.72
Valuation
Enterprise Value -95.67M-51.65M-101.90M-271.18M-327.40M-299.92M-274.59M-248.31M-225.97M-204.99M-184.11M
Return Ratios
Return on Sales -1.36%-1.15%-1.60%-1.56%-2.25%-0.54%-1.63%-2.43%-6.07%-2.34%-2.36%
Return on Capital Employed -0.28%-0.25%-0.27%-0.29%-0.32%-0.36%-0.40%
Return on Invested Capital 1.23%-1.38%-0.33%-0.33%-0.34%-0.37%-0.43%-0.49%
Return on Assets -0.20%-0.19%-0.20%-0.23%-0.25%-0.31%-0.34%
Return on Equity 0.94%-1.10%-0.28%-0.28%-0.32%-0.35%-0.43%-0.47%